The single-center, randomized, open-label, five-period crossover bioavailability study will include 30 subjects who will test five CoQ10 formulations. Study will be conducted with single dose CoQ10 to assess bioavailability.
The single-center, randomized, open-label, five-period crossover single-dose bioavailability study with five CoQ10 formulations